Use of sacubitril/valsartan in patients with heart failure: evidence from the real world

CONCLUSIONS: The persistence of treatment 1 year after starting sacubitril/valsartan was not high, and a small proportion of patients reached the target dose of the drug. Nontitration of the drug dose was common.PMID:38051633 | DOI:10.1080/14656566.2023.2287667

Source: Expert Opinion on Pharmacotherapy - December 5, 2023 Category: Drugs & Pharmacology Authors: Luis Fernando Valladales-Restrepo Nicol ás Sánchez-Ramírez Andr és Felipe Usma-Valencia Santiago Vel ásquez-Quirama Manuela Henao-Mart ínez Jorge Alejandro Castro-Rodriguez Andr és Gaviria-Mendoza Manuel Enrique Machado-Duque Jorge Enrique Machado- Source Type: research